Early Look

Wednesday, March 11, 2026

Futures

Up/Down

%

Last

Dow

55.00

0.12%

47,800

S&P 500

10.25

0.15%

6,797

Nasdaq

31.50

0.12%

25,013

 

 

U.S. futures are rebounding off the lows after choppy trading overnight as markets digest new attacks in the Middle East, rising oil prices, better earnings/guidance out of Oracle (shares +10%), and positioning ahead of the February Consumer Price Index (CPI) inflation data at 8:30 am et this morning. Another story getting attention this morning comes from the Financial Times which reported JPMorgan Chase & Co. is restricting some lending to private credit funds after marking down the value of certain loans in their portfolios. Energy prices whipsawed as traders weighed a report that the International Energy Agency was looking at releasing oil reserves to stabilize supply. Tensions remain high in the Middle East as the UK Navy said three vessels were hit with suspected projectiles in the Strait of Hormuz and Persian Gulf on Wednesday, as the conflict in the region continues to menace shipping. The targets include a cargo ship in the Strait of Hormuz off Oman, a container vessel west of Ras Al-Khaimah and a bulk carrier northwest of Dubai, the UK Maritime Trade Operations Center said. WTI crude +2.5% at $85.50 (overnight high $88.99 and low $81.79) and gold prices are falling. In Asian markets, The Nikkei Index jumped 776 points to 55,025, the Shanghai Index gained 10 points to 4,133, and the Hang Seng Index fell -61 points to 25,898. In Europe, the German DAX is down around -300 points to 23,663, while the FTSE 100 is down -75 points to 10,336. Japan to release 15 days’ worth of private-sector oil reserves and one-month worth of State oil reserves notes PM Takaichi.

 

Market Closing Prices Yesterday

  • The S&P 500 Index dipped -14.51 points, or 0.21%, to 6,781.48
  • The Dow Jones Industrial Average fell -34.29 points, or 0.07%, to 47,706.52
  • The Nasdaq Composite edged higher 1.16 points, or 0.01%, to 22,697.10
  • The Russell 2000 Index declined -5.59 points, or 0.22% to 2,548.08

Economic Calendar for Today

  • 7:00 AM ET MBA Mortgage Applications Data
  • 8:30 AM ET                   Consumer Price Index (CPI) M/M for February…est. +0.3% (prior +0.2%)
  • 8:30 AM ET                   Consumer Price Index (CPI) Y/Y for February…est. +2.4% (prior +2.4%)
  • 8:30 AM ET                   Core CPI, Ex: Food & Energy M/M for February…est. +0.2% (prior +0.3%)
  • 8:30 AM ET                   Core CPI, Ex: Food & Energy Y/Y for February…est. +2.5% (prior +2.5%)
  • 10:30 AM ET                 Weekly DOE Inventory Data
  • 1:00 PM ET U.S. Treasury to sell $42B in 10-year notes
  • 2:00 PM ET                    Federal Budget for February

Earnings Calendar:

  • Earnings Before the Open: ACTG BWAY BWEN CPB CVGI CXM KMDA KPLT OPFI SDHC SERV TH
  • Earnings After the Close: ARIS ASTL BMBL CDXS CINT CURI DMRC DSGC DSP FOSL FTK HPK NOA NTSK NVGS ODC PATH SFIX SID TBBB TLYS TTGT VEL WLTH WOOF

Other Key Events:

  • Bank America Consumer & Retail conference, 3/9-3/12
  • Cantor Technology Conference, 3/10-3/11
  • Deutsche Bank 34th Annual Media, internet & Telecom Conference, 3/9-3/11, in Palm Beach, FL
  • RBC Capital 2026 Global Financials Conference, 3/10-3/11, in New York
  • Stifel NYC technology 1-on-1 Conference, 3/11 in New York

 

 

Macro

Up/Down

Last

Nymex

2.22

85.67

Brent

2.91

90.71

Gold

-56.00

5,186.10

EUR/USD

-0.0003

1.161

JPY/USD

0.29

158.33

10-Year Note

+0.027

4.163%

 

World News

  • The International Energy Agency (IEA) is recommending a large-scale release of oil from strategic reserves that would exceed 100 million barrels over the first month, two sources with knowledge of IEA discussions said on Wednesday, to help restrain soaring crude prices amid the U.S.-Israel war with Iran. Spain's Energy Minister Sara Aagesen said the proposed release would be the largest in IEA history, more than double the level from the start of the Ukraine war four years ago. The IEA did not immediately respond to a request for comment.

Sector News Breakdown

Consumer

  • Cintas (CTAS) to acquire UniFirst (UNF) for $310.00 per share in cash and stock in $5.5B transaction; UniFirst shareholders to receive $155 cash and 0.7720 Cintas shares per share
  • Nature’s Sunshine Products (NATR) Q4 EPS $0.23 vs est $0.19, adj EBITDA $11.9Mm vs est $10.47Mm on revs $123.8Mm vs est $121.62Mm, gr mgn 72.5%; sees FY sales $500-515Mm vs est $494.39Mm and adj EBITDA $50-54Mm vs est $51.21Mm.
  • Nike (NKE) was upgraded to Overweight from Equal Weight at Barclays and raise tgt to $73 from $64 citing Nike's operational progress, financial inflections, and management's disciplined actions for the upgrade; says the stock's risk/reward profile has shifted favorably, creating an attractive investment opportunity.
  • Porsche (POAHY) said it expects its operating margin to rise this year, guiding a group operating return on sales in the range of 5.5% to 7.5% in 2026, after collapsing to 1.1% in 2025.
  • Starboard Value has taken a stake in CarMax (KMX) and nominated two directors to its board, urging the used car retailer to improve the experience of its digital users, cut costs and change its pricing structure. Starboard now owns roughly $350 million worth of shares in CarMax.
  • Target (TGT) said ‌that it ‌was lowering prices on ​over 3,000 products across its apparel, home goods ‌and other daily items, most of which are 5% to ‌20% lower ​than ​the ​original price, ‌will start in ​March, ​the company said.
  • Tesla’s (TSLA) China-made electric vehicle rose ‌for a fourth month in ‌a row in February, as sales of Model 3 and Model Y vehicles ‌made in its Shanghai plant totalled 58,600 units last month, up 91% from a year earlier and ​following a ​9.3% rise ​in January.
  • Westrock Coffee (WEST) Q4 EPS ($0.23) vs est ($0.16), adj EBITDA $23.0Mm vs est $15.43Mm on sales $339.472Mm vs est $317.4Mm; guides FY adj EBITDA $90.0-100.0Mm vs est $105.98Mm.
  • Xponential Fitness (XPOF) announced that John Meloun, Chief Financial Officer, has separated from the Company effective March 9, 2026. Robert Julian has been appointed interim Chief Financial Officer, effective March 16, 2026; they also reaffirm guidance.

Energy, Industrials and Materials

  • AeroVironment (AVAV) Q3 adj EPS $0.64 vs. est. $0.69 and revs $408M below consensus $475M; Q3 gross margins; guides FY revenue $1.85B-$1.95B vs. est. $1.966B and sees FDT adj Ebitda $265-$285 million below the consensus $297.1M; Q3 Bookings were $2.1B and book-to-bill ratio of 1.6 for the first nine months of the fiscal year and Record funded backlog of $1.1B.
  • Concrete Pumping Holdings (BBCP) Q1 EPS ($0.06) vs est ($0.08), adj EBITDA $18Mm vs est $16.33Mm on revs $90.561Mm vs est $84.82Mm; guides FY revs $390-410Mm vs est $398.6Mm, adj EBITDA $90-100Mm vs est $96.63Mm and FCF at least $40Mm.
  • Diamondback Energy Inc (FANG) announces secondary offering of 11M shares by SGF Fang Holdings
  • Kosmos (KOS) 97.5M share Spot Secondary priced at $1.90.
  • Smurfit Westrock (SW) plans to invest $5B in U.S. operations as part of a broader $6.1B Irish investment pledge ahead of Ireland’s St. Patrick’s Day White House visit – WSJ reports.
  • SolarEdge Technologies (SEDG) said finance chief Asaf Alperovitz will step down from his role and that they have begun a process to find a replacement for Alperovitz, who will continue to serve as finance chief until June 9.

Financials

  • Brandywine Realty Trust (BDN) files for mixed shelf of up to $300M
  • Invesco Ltd. (IVZ) preliminary month-end assets under management (AUM) of $2,257.7B, an increase of 1.2% versus previous month-end. The firm delivered net long-term inflows of $4.7B in the month. Money market net inflows were $13.5B. AUM was positively impacted by favorable market returns which increased AUM by $9B.
  • JPMorgan Chase & Co. (JPM) is restricting some lending to private credit funds after marking down the value of certain loans in their portfolios, according to a person familiar with the matter, the Financial Times reported. The devalued loans are to software companies, the person added, a sector that’s been in the spotlight in recent weeks due to investor concern over the potential impact of artificial intelligence.
  • Loan Depot (LDI) Q4 adj EPS ($0.10) vs est ($0.04), adj EBITDA $29.316Mm on revs $310.26Mm vs est $333.93Mm

Technology, Media & Telecom

  • Oracle Corp. (ORCL) Q3 adj EPS $1.79 tops consensus $1.70 and revs rose 22% y/y to $17.2B vs. est. $16.91B; Q3 adj net income $5.2B vs. est. $4.99B; Q3 Remaining Performance Obligations (RPO) $553B, up 325% y/y; Q3 Cloud Revenue (IaaS plus SaaS) $8.9B, up 44% y/y; Q4 total REVs are expected to grow from 18% to 20% in constant currency, Q4 EPS expected to grow between 15% to 17% and be between $1.92 and $1.96 in constant currency and Q4 total Cloud revs is expected to grow between 44% to 48% in constant currency; said it has already raised $30B of the $50B it said it needed in February via the debt and equity markets.
  • Blend Labs (BLND) preliminary Q4 adj operating Income $5.4Mm vs est $3.093Mm on revs $32.4Mm vs est $31.78Mm, adj gr mgn 80%; guides Q1 revs $28.5-30.0Mm vs est $31.48Mm and adj EBIT $2.0-3.0Mm vs est $3.98Mm.
  • Domo Inc. (DOMO) Q4 adj EPS $0.03 vs. est ($0.03) on revs $79.625Mm vs es T$78.65Mm, adj Operating margin 10%.
  • Evolv Technologies (EVLV) Q4 adj EPS ($0.03) vs est ($0.02), adj EBITDA $1.8Mm vs est $1.945Mm on revs $38.5Mm vs est $36.44Mm; guides FY revs $172-178Mm vs est $164.9Mm and adj EBITDA mgn high-single-digits.
  • Groupon Inc. (GRPN) Q4 adj EPS $0.17 and sales rose 1.8% y/y to $132.7M vs. est. $137.3M; Ad adj Ebitda was $20.9M and Q4 billings $446.5M.
  • Microsoft (MSFT) threw its support behind Anthropic on Tuesday and advocated for a temporary restraining order that would block the Pentagon’s supply chain risk designation. The move would “enable a more orderly transition and avoid disrupting the American military’s ongoing use of advanced Ai,” Microsoft said in a filing

Mid-Morning Look

Wednesday, March 11, 2026

Index

Up/Down

%

Last

DJ Industrials

-242.19

0.51%

47,464

S&P 500

2.94

0.04%

6,784

Nasdaq

86.49

0.38%

22,783

Russell 2000

-6.81

0.27%

2,541

 

 

U.S. stocks are trading moderately higher after futures bounced between gains and losses overnight. The February consumer price index (CPI) inflation report was welcomed by investors with in-line results vs. consensus views and the prior month, giving investors a pause for concern ahead of this Friday’s PCE index reading. Tech space getting a double dose of positive news as Oracle (ORCL) shares jump 12% following better earnings/guidance and in-line capex, while the data infrastructure/AI sector rises as NBIS shares jumps as NVDA announced a strategic partnership (investing $2B) to develop and deploy the next Generation of hyperscale Cloud for the Ai market, from Ai natives to enterprises. That has the HPC Data center stocks moving higher (IREN, CIFR, WULF, CRWV). Private Equity/credit lenders seeing weakness again (ARES, CG, APO, KKR, OWL) after the Financial Times reported JPM is restricting some lending to private credit funds after marking down the value of certain loans in their portfolios. Early weakness as well in consumer staples (XLP) after Campbells (CPB) misses earnings and lowers guidance hitting food stocks. Energy and tech early bright spots.

 

Energy prices whipsawed as traders weighed reports as the 32 Member countries of the International Energy Agency (IEA) unanimously agreed today to make 400 million barrels of oil from their emergency reserves available to the market to address disruptions in oil markets stemming from the war in the Middle East. Earlier, reports showed Germany and Japan were looking at releasing oil reserves to stabilize supply ahead of a decision by the International Energy Agency, in the face of intensifying air strikes in the Middle East that are likely to ground shipping through the strategic Strait of Hormuz for a while. Oil prices were very choppy again this morning. Until the Strait of Hormuz is opened and the turmoil in the Middle East simmers down, oil prices remain elevated. President Trump also told Axios in a brief phone interview Wednesday that the war with Iran will end "soon" because there is "practically nothing left to target."

 

Higher oil prices from the Iran conflict have driven a hawkish repricing in rates, flattening yield curves and lifting real rates while weakening the hedging value of nominal duration. Front-end yields have climbed more in Europe and the UK than in the US, where markets still expect Fed cuts in 2026. While upside oil risks remain, moderating core inflation and softer labor markets limit hawkish pressure. The 10-year yield scales 4.18% this morning.

 

Economic Data

  • February U.S. CPI came in at +0.3% M/M vs. +0.3% consensus and +0.2% prior. On an annual basis it came in at +2.4% Y/Y vs. +2.4% consensus and +2.4% in January. The core CPI (excludes food and energy) was +0.2% M/M vs. +0.2% consensus and +0.3% prior and +2.5% Y/Y vs. +2.5% consensus and +2.5% prior.

 

 

Macro

Up/Down

Last

WTI Crude

1.93

85.38

Brent

3.04

90.93

Gold

-46.50

5,195.60

EUR/USD

-0.0015

1.1595

JPY/USD

0.46

158.50

10-Year Note

0.049

4.185%

 

Sector Movers Today

  • Private Credit/PE space in focus (APO, ARES, BX, CG, KKR, OWL), as the Financial Times reported JPM is restricting some lending to private credit funds after marking down the value of certain loans in their portfolios, according to a person familiar with the matter, the Financial Times reported. The devalued loans are to software companies, the person added, a sector that’s been in the spotlight in recent weeks due to investor concern over the potential impact of artificial intelligence. Separately, Bloomberg reported that Private Credit Fund Cliffwater LLC is facing redemption requests in excess of 7% from its flagship private credit fund. The $33B Cliffwater Corporate Lending Fund is structured as an interval fund, requiring it to repurchase up to 5% of its shares each quarter if investor requests meet that threshold. If redemptions exceed 5%, has discretion to repurchase as much as 7% of shares.
  • In Autos: KMX shares rallied after Starboard Value has taken a stake in the company and nominated two directors to its board, urging the used car retailer to improve the experience of its digital users, cut costs and change its pricing structure. Starboard now owns roughly $350 million worth of shares. TSLA’s Shanghai factory reached 58,600 units in February, representing a 91% increase y/y, Shanghai Securities News reports, citing Tesla China. Porsche (POAHY) said it expects its operating margin to rise this year, guiding a group operating return on sales in the range of 5.5% to 7.5% in 2026, after collapsing to 1.1% in 2025. Aston martin (ARGGY) was downgraded at Bernstein after the company announced a significant reduction in mid-term volume plans. NIO upgraded from Neutral to Buy at Nomura as believes NIO is finally entering into a healthy business Cycle.
  • Leisure Sector: Well Fargo initiated DOOO, PLNT, LTH, MAT all initiated at Overweight; HAS, MTN, PII initiated at Equal Weight and HOG initiated at Underweight ($15 PT) in Leisure sector with preference for secular tailwinds in Fitness and relative Defense/optionality in toys. They are selective in powersports on tepid demand; skew high-income in K-shaped backdrop + BBB stimulus. Says durable wellness tailwinds and healthy growth leave US constructive on the outlook for LTH and PLNT Risk/reward balanced in MTN on weak demand/execution challenges at a low multiple. Likes the HAS story but struggle to see how the stock works on tough comps.
  • In MedTech: ISRG was upgraded Intuitive Surgical to Buy from Neutral with an unchanged price target of $590 as believes fundamentals in the U.S. medical technology sector remain healthy despite the recent volatility. Citi also opened an "upside 90-day catalyst watch" on SYK while keeping a Buy rating as believes fundamentals in the U.S. medical technology sector remain health despite the recent volatility. Citi's Top Picks include IRTC particularly given the pullback on DOJ concerns and MDT given new product cycles that should accelerate growth.

 

Stock GAINERS

  • DOMO +21%; after results as reported 1.3% revenue beat to Street topline expectations, driven by 1.7% beat to the Street's subscription revenue forecasts; Growth was supported by record quarterly billings, improved gross retention (highest in three years), and net retention improvement (+4pts Y/y to 96%).
  • KMX +2%; shares rallied after Starboard Value has taken a stake in the company and nominated two directors to its board, urging the used car retailer to improve the experience of its digital users, cut costs and change its pricing structure. Starboard now owns roughly $350 million worth of shares.
  • NBIS +16%; and NVDA partner to scale full-stack AI cloud as NVIDIA to invest $2 billion in Nebius; Nebius to deploy more than 5 GWs of NVIDIA systems by end of 2030.
  • NKE +1%; was upgraded to Overweight from Equal Weight at Barclays and raise tgt to $73 from $64 citing Nike's operational progress, financial inflections, and management's disciplined actions for the upgrade; says the stock's risk/reward profile has shifted favorably, creating an attractive investment opportunity.
  • ORCL +13%; reported better-than-expected Q3 results, featuring Cloud revenue growth coming in at the high end of guidance for the first time in over 2 years, anchored by 84% OCI growth, 20%+ revenue and EPS growth, and operating margin upside
  • SERV +16%; shares jumped after released Q4 results and launches Autonomous delivery with White Castle via Uber Eats; said expects 2026 capital expenditures of approximately $25M.
  • UNF +9%; after CTAS to acquire UniFirst for $310.00 per share in cash and stock in $5.5B transaction; UniFirst shareholders to receive $155 cash and 0.7720 Cintas shares per share.
  • UPST +1%; as the firm plans to apply for a US national bank charter, aiming to reduce costs and streamline its AI-based lending platform

 

Stock LAGGARDS

  • AVAV -6%; Q3 results were impacted by revenue timing and adjustments within the Space business, with adjusted EBITDA of $44.5M (vs. consensus $64.2M) and non-GAAP EPS of $0.64 (consensus $0.66), on revenue of $408.0M, up 38% Y/y organically (consensus $478.0M), while lowered its FY26 guidance more than expected.
  • CPB -8%; reported Q2 top and bottom line results below consensus and cut its annual sales and profit forecasts; now sees FY26 organic net sales to fall between 1%-2%, compared with its previous forecast of between a -1% fall and 1% rise; also sees Fy26 EPS in range of $2.15-$2.25, below its prior view of $2.40-$2.55.
  • KOS -18%; as 97.5M share Spot Secondary priced at $1.90.
  • OWL -3%; along with ARES, APO, BX, KKR as the Financial Times reported JPM is restricting some lending to private credit funds after marking down the value of certain loans in their portfolios.
  • SEDG -2%; said finance chief Asaf Alperovitz will step down from his role and that they have begun a process to find a replacement for Alperovitz, who will continue to serve as finance chief until June 9.
  • SLB -1%; after saying escalating tensions in the Middle East would hit its Q1 EPS by about $0.06-$0.09 and push revenue below expectations, as energy companies move to safeguard personnel and facilities across the region.

Closing Recap

Tuesday, March 10, 2026

Index

Up/Down

%

Last

DJ Industrials

-34.23

0.07%

47,706

S&P 500

-14.46

0.21%

6,781

Nasdaq

1.16

0.01%

22,697

Russell 2000

-5.59

0.22%

2,548

 

 

 

 

 

 

 

 

 

U.S. stocks were stronger most of the morning, then very choppy and volatile this afternoon with headlines coming out of the White House and media about Middle East actions, leading to massive swings in oil markets which consequently moved stock markets, which ended lower.  Oil prices plummeted on Tuesday (though finished off their worst levels) after soaring to a more than three-year high in the previous session as U.S. President Donald Trump predicted the war in the Middle East could end soon, easing concerns about prolonged disruptions to oil supplies. Fear also plummeted as the VIX, after peaking above 32, down 25% from intraday high Monday, but ended around 25.50. Headlines like, “U.S. Intelligence assets have begun to see indications Iran is taking steps to deploy mines in strait of Hormuz Shipping Lane – CBS news reporter on X” were flowing all afternoon and impacting market sentiment. Next catalysts on deck are tonight’s Oracle (ORCL) earnings in software/AI, and February CPI inflation data tomorrow morning.

 

Oil prices were already pulling back this morning, but selling accelerated after U.S. Energy Secretary Chris Wright said on social media that the U.S. Navy successfully escorted an oil tanker through the strait of Hormuz to ensure oil remains flowing to global markets. That pushed WTI crude to lows 0f $76.73 per barrel. But shortly after, The Secretary of Energy Wright then deleted that same post, causing a bounce off lows for oil prices which remain very volatile (WTI closed around $91 last Friday, hit highs just below $120 a barrel on Sunday night, traded down below $90 on Monday and then hit lows of $76.73 this morning in chaotic trading over the Middle East tensions. The U.S. has not yet escorted any oil tankers or vessels through the Strait of Hormuz, White House Press Secretary Karoline Leavitt confirmed.

 

In stock news, selling pressure in software stocks ahead of ORCL earnings tonight as traders lock in some profit taking in the group after a 2-week bounce. Some strength in tech, specifically, optical/Infrastructure stocks (DY, MTZ, GLW, LITE, CIEN) given AT&T (T) announcing a large capex figure saying they plan to invest more than $250 billion over five years in the U.S. to build out its network infrastructure (investment compares with analysts' estimates of $111.61B in capex through 2030). In sector news, energy (XLE) was the biggest laggard in the S&P behind the oil price drop along with healthcare on managed care weakness (CNC CEO comments weighed). On the positive side, modest gains for Materials, Tech and Consumer Staples and Discretionary.

Economic Data

  • February Existing Home Sales unexpectedly rose 1.7% at a 4.09M unit rate, above consensus 3.89M and vs Jan 4.02M (vs Jan -5.9%) as inventory of homes for sale 1.29M units, 3.8 months' worth. The Feb National median home price for existing homes $398,000, +0.3% from Feb 2025.

Commodities

  • Oil prices tumbled and equities rebounded, continuing the volatility in energy markets after soaring to their highest levels since 2022 in the previous session after U.S. President Donald Trump predicted the war with Iran could end soon, lowering expectations of prolonged oil supply disruptions. Headlines were plentiful, some bearish, some bullish for commodity markets, but by day’s end, U.S. WTI crude oil futures settled at $83.45/bbl, down $11.32, or 11.94% (traded high to lows $91.48 and $76.73). Brent Crude futures settle at $87.80/bbl, down $11.16, or 11.28%. Both crude benchmarks surged to more than $119 a barrel on Monday to their highest since June 2022 as supply cuts by Saudi Arabia and other producers stoked fears of major disruptions.
  • April gold prices rose $138.40, around 2.7% to settle at $5,242.10 boosted by a pullback in the U.S. dollar and easing inflation concerns as oil prices pulled back amid indications the conflict in the Middle East could end soon. Inflation concerns remain in the forefront tomorrow with the January Consumer Price Index (CPI). Spot silver rose 2.7% to $89.39, spot platinum gained 2.2% at $2,229.15, while palladium fell 0.9% to $1,675.50.

 

Macro

Up/Down

Last

WTI Crude

-11.32

83.45

Brent

-11.16

87.80

Gold

138.40

5,242.10

EUR/USD

-0.0023

1.1613

JPY/USD

0.39

158.03

10-Year Note

-0.00

4.136%

 

Sector News Breakdown

Autos:

  • In Chinese EVs: NIO Q4 Adj. EPS: RMB0.29 and sales rose 75.9% y/y to $4.95B; delivers Q4 record 124,807 deliveries (+71.7% YoY), first non-GAAP operating profit CNY 1.25B, margin expansion to 17.5%, and strong Q1 guide (80k-83k deliveries, rev up 103-109% YoY).
  • In Electric Vehicles: RIVN was upgraded to Buy at TD Cowen and raised tgt to $20 following a detailed R2 demand analysis as they see full scale R2 demand at 212,000-335,000 units, suggesting upside to consensus forecasts.
  • In Autos: STLA is leaning on technologies from automotive suppliers for its newest hybrid SUVs, CNBC has learned. VWAGY reported a slump in operating profit and forecast only a modest recovery. Said it expects an operating margin of between 4%-5.5% in 2026, after 2.8% in 2025 and 5.9% a year earlier (vs. ests 4.2%) at the higher end of the company's forecast range; operating profit for 2025 more than halved to 8.9B euros ($10.4 billion), missing analysts' forecast of 9.4B euros, dragged by tariffs and a costly strategic shift at Porsche

Retail, Consumer Staples & Restaurants:

  • In Department Stores: KSS Q4 revs fell -3.9% y/y to $4.97B missing the $5.03B estimate, while EPS of $0.95 beat the $0.85 consensus and Q4 operating income rose to $212M from $126M y/y; Q4 GMs rose 25bps and SG&A expenses fell -4.9% y/y; guided full-year sales to be flat to decline 2% vs. est. -0.7%.
  • In Food & Beverages: chocolate players were weak initially (MDLZ, HSY) after Lindt & Spruengli lowered its sales outlook for 2026 because of weak consumer sentiment dampened by higher fuel prices, Chief Executive Adalbert Lechner said; sales in the Middle East directly affected by the Iran crisis were negligible, but lower numbers of people travelling via the region's airport hubs would reduce sales
  • Food Processing: BG said it expects earnings to increase to at least $15 per share by 2030 and announces a new $3 billion share repurchase program while a also sets a mid-cycle earnings baseline of about $13 per share

Leisure, Gaming & Lodging:

  • Teme Parks: Keybanc said their domestic geolocation data tracking Theme Park attendance appears negative; DIS attendance was +2% y/y vs. +7% in Feb., and CMCSA’s Universal was +26% vs. +42% in Feb., with an underlying slowdown in Universal Orlando, ex EPIC. Overall, they say it's too early to call the quarter as March represents spring break period, which decides the quarter given the concentration of attendance. (says QTD trends are fine).
  • In Leisure Sector: Ski resort operator MTN reported Q2 net income fell y/y due to challenging weather conditions and adj EPS $5.87 missed ests $6.09 posting a 13% drop in visitation, while lift revenue declined only -2.9% due to a 3% increase in N.A. pass sales revenue; lowers FY26 net income guidance to $144M-$190M and guided FY resort EBITDA $745-775M (down from prior view $842M-$898M) citing challenging weather in Rockies.

Energy & Industrials

  • In Solar: SEDG was upgraded to Neutral from Underperform at Bank America and raise PT to $40 from $17 as margin trajectory, revenue cadence and liquidity have all stabilized enough to materially reduce downside risk, with FY26 revenue of roughly $1.35B supported by SEDG's structurally advantaged positioning in TPO channels. Also note the company regained the top U.S. inverter share in Q2 and Q3 of 2025 for the first time since Q3’21.

Asset Managers:

  • Financial Services: FICO shares tumbled after Stifel noted today, each credit bureau announced a new, lower priced mortgage origination score of $0.99-$1.00 for VantageScore 4.0 (TRU and EXPN at $0.99, and it looks like EFX is the “premium” provider at $1.00). This is a material pricing differential relative to FICO’s current $10 price today if mortgage lenders purchase FICO through the credit bureaus, and a significant discount to the $4.95 price for FICO if the score was purchased through its Direct License program.
  • Asset Managers: CNS preliminary assets under management of $98.4B as of February 28, 2026, an increase of $5.4B from assets under management of $93.1B at January 31, 2026. The increase was due to market appreciation of $5.5B and net inflows of $7M, partially offset by distributions of $151M. LAZ preliminary assets under management as of February 28, 2026, totaled approximately $277.7B. The month's AUM included market appreciation of $8.9B, net inflows of $4.2B, FX depreciation of $0.8B and a decrease of $1.5B related to the sale of our stake in the Edgewater Funds management vehicles.

Biotech & Pharma:

  • BBIO shares jumped following a positive court case update for PFE as Evercore noted based on a court update just now, Pfizer’s patent position on tafamidis polymorph patent infringement got meaningfully stronger just now. Tafamadis has a court trial on IP starting in late April. Among the generic filers on Vyndamax, the first to file (Dexcel) has already agreed to infringement meaning, they are aiming for invalidity of the 2035 polymorph patent. Meanwhile, Hikma and Cipla had an added line of defense vs Pfizer: non-infringement of polymorph. Based on a court update just now, I think Hikma and Cipla’s non-infringement position has weakened meaningfully ahead of the trial, which was seen as positive for BBIO.
  • BNTX shares fell after the company said its co-founders are leaving the company to found a new independent venture by the end of 2026; adds it will contribute to the new co with rights and mRNA technologies in exchange for a minority stakeBeat; also reported earnings as FY revs EU2.87B topped ests EU2.74B, while FY26 sales guidance EU2.33B-EU2.68B below EU3.12B estimate on pipeline doubts and oncology ramp delays.
  • CRSP announced a proposed $350M convertible Senior notes offering.
  • PRTA announced they earned a $50M milestone payment from NVO related to the achievement of a prespecified enrollment target in the ongoing Phase 3 CLEOPATTRA clinical trial evaluating coramitug, a potential first-in-class amyloid depleter antibody, for the treatment of ATTR.
  • VRTX said that its experimental kidney disease drug met the main goal of a late-stage trial; the experimental drug successfully reduced by half a key marker of an autoimmune kidney disease known as IgA nephropathy
  • XAIR announces termination of agreement to sell its Neuronos subsidiary to XTL Biopharmaceuticals Ltd.; says to evaluate strategic alternatives for Neuronos and focus on LungFit programs.

Healthcare Services & MedTech movers:

  • HIMS was upgraded from Sell to Neutral at Bank America on official announcement that it has renewed its partnership with NVO to sell Ozempic and Wegovy (injections and tablets) off its platform. HIMS was also upgraded to Neutral from Sell at Citigroup.
  • LFMD reported a Q4 top- and bottom-line beat as FY26 revenue guidance was slightly above consensus, but FY26 adj. EBITDA guidance was below consensus; said expects an adj. EBITDA loss of $4M-$5M in 1Q26 but a return to profitability in 2Q26; guides FY revs $220-230Mm vs est $222.62Mm.
  • MDT said it has agreed to acquire neurovascular technology company, Scientia Vascular, for $550M, with potential undisclosed earn-out and milestone payments post-acquisition.
  • TDOC was upgraded to Buy from Hold at Deutsche Bank with an $11 price tgt given what they see as a compelling valuation, a deliverable strategy for the BetterHelp business and a comparable transaction illustrating the road map as a potential path forward.
  • In Managed care (UNH, HUM): Citing a congressional investigation, The Wall Street Journal reported that due to alleged overpayments to Medicare Advantage health plans, Medicare Part B premiums increased by $13.4B last year, with most of that cost borne by seniors. The committee found that the average American senior’s Medicare premiums rose about 10%, or more than $200 annually, due to the alleged overpayments last year. CNC shares fell after the company reaffirms its recently lowered 2026 outlook and said plans to redeem $1B in notes. CNC CEO said at the Barclays Healthcare Conference that the company expects mid-30% of membership in ACA's bronze plan, high-teens percentage in its gold plan and just under 50% of members in its silver plan, which is lower than it has been in the past years

Aerospace & Defense

  • The air-taxi business got a boost late Monday (ACHR, BETA, JOBY) after the Transportation Department unveiled selections for its pilot program for testing next-generation aircraft; but the group slipped today.
  • JOBY announced it has been selected as a partner in multiple winning applications under the White House-backed Electric Vertical Takeoff and Landing Integration Pilot Program, allowing the company to begin early operations this year in 10 US states.
  • VOYG Q4 revs missed as $46.65M vs. est. $48.2M; says demand across Defense, National Security and space continues to accelerate; Q4 Income from operations $-34.029M; raises 2026 revenue guidance to $225M-$255M; Q4 Record year-end Total Backlog of $265.6M, an increase of 33% y/y.

Internet, Media & Telecom

  • In Telecom: AT said it plans to invest more than $250 billion over five years in the U.S. to build out its network infrastructure. Rising AI adoption is driving growth in data traffic and cloud connectivity needs, increasing demand for high-capacity telecom networks, fiber infrastructure, and low-latency services to support the workloads. The investment compares with analysts' estimates of $111.61B in cap-ex through 2030.
  • In Online Services: YEXT shares slipped after FQ426, with revenue/adj. EBITDA of $112.0M/$29.0M vs consensus' $113.6M/$27.7M, while the company plans to suspend quarterly earnings calls and quarterly/annual guidance amid focus on driving LT value.

Hardware & Software movers:

  • Software: ORCL is expected to report earnings tonight after the close, which follows reports last Friday that reports that the company has axed plans to expand an AI data center with OpenAI and that it’s preparing to cut thousands of jobs. Oracle has fallen steeply. After climbing to a high of $345.72 in September, the stock was trading at $154. Shares are now off 37% over the last six months and 23% since the start of the year.
  • Security Software: CRWD was upgraded to Overweight from Equal Weight at Morgan Stanley PT $510 saying sees multiyear 20%+ rev growth potential supported by strong positioning in EDR and platform across Cloud, Identity, SIEM and Ai.
  • In Optical and Tech Hardware & Comm: shares of optical players AAOI, LITE, CIEN, COHR resumed their upside momentum after briefly pulling back late last week in the tech sell off, helped by AT capex spending news . HPE reported Q4 revenue $9.301B, +18.4% y/y (last q +14.4% y/y) vs Street about $9.33B-$9.35B, +~18.8%-19.0% y/y; EPS was $0.65 vs Street $0.58-$0.59; non-GAAP gross margin was 36.6% vs Street 35.8%; Networking revenue was $2.706B, +152% y/y reported / +~7% normalized vs Street about $2.70B, and HPE raised FY26 networking growth to 68%-73%.

Semiconductors:

  • QCOM was reinstated at Underperform (down from Neutral prior) at Bank America with $145 tgt noting it is the leader in smartphone processors, but it's a mature industry with downside risks from rising memory prices and cites the well-known imminent $7B-$8B loss of AAPL business.
  • TSM January-February revenue rose 30% to NT$718.91B; February revenue fell 21% on the month; February revenue rose 22% on year to NT$317.66B from NT$260.01B.
  • Memory names SNDK, MU shares jumped after Digitimes.com reported NAND flash prices have surged amid tightening supply, with some manufacturers raising quotations by as much as 50% overnight, according to Phison Electronics CEO Khein-Seng Pua.

Not offered or endorsed by Regal Securities

Street Recommendations

Wednesday, March 11, 2026

ARGUS

  • NVS Argus analyst David Toung upgraded Novartis to Buy from Hold with an $180 price target. The firm is citing the company's "strong volume growth" of 18% in Q4 and high dividend while noting that after the recent pullback in shares, investors face an "attractive entry point", the analyst tells investors in a research note.

BARCLAYS

  • NKE Barclays upgraded Nike to Overweight from Equal Weight with a price target of $73, up from $64. The firm cites Nike's operational progress, financial "inflections," and management's "disciplined actions" for the upgrade. The stock's risk/reward profile has "shifted favorably," creating an attractive investment opportunity, the analyst tells investors in a research note. Barclays believes Nike's progress in inventory management, operational resets, and focus on brand health and margin stabilization "provide a solid foundation for a more constructive investment thesis." The worst of the tariff and geopolitical risk may be behind the company, adds the firm.
  • HIMS Barclays analyst Glen Santangelo raised the firm's price target on Hims & Hers to $29 from $25 and keeps an Overweight rating on the shares. The rally post the Novo Nordisk agreement highlights the incremental market opportunity and removal of the legal overhang for Hims & Hers shares, the analyst tells investors in a research note. Barclays believes the market is still underappreciating Hims' opportunity from new products.
  • ORCL Barclays raised the firm's price target on Oracle to $240 from $230 and keeps an Overweight rating on the shares following the fiscal Q3 report. Barclays sees the shares "starting to work better from here," saying the Q3 print addressed several investors concerns around capital expenditures, the gross margin profile of contracts and Oracle's ability to deliver capacity on time. In addition, other parts of the business, like software-as-a-service and maintenance, are performing well, creating "plenty of upside" from current share levels, the analyst tells investors in a research note.
  • NVMI Barclays analyst Tom O'Malley initiated coverage of Nova with an Overweight rating and $465 price target. As the industry transitions to more metrologically intensive technologies, Nova has "multiple avenues of growth" amid accelerating wafter fab equipment spending, the analyst tells investors in a research note. The firm says the company addresses both the front and back-end through dimensional, chemical, and materials metrology.
  • AJG Barclays upgraded Arthur J. Gallagher to Overweight from Underweight with a price target of $262, up from $247. The insurance broker group has "derated sharply on fears of AI-driven disruption," the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now "more than discount" slower growth while overlooking durability of the broker business model and AI's potential to support productivity and margins. The analyst views AI as a "productivity enabler" for the brokers. Barclays says Arthur J. Gallagher is "one of the best ways to play defense in this environment."
  • WTW Barclays upgraded WTW to Equal Weight from Underweight with a price target of $341, up from $318. The insurance broker group has "derated sharply on fears of AI-driven disruption," the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now "more than discount" slower growth while overlooking durability of the broker business model and AI's potential to support productivity and margins. The analyst views AI as a "productivity enabler" for the brokers. Barclays says WTW's specialty strategy is proving more durable than expected.
  • BRO Barclays analyst Alex Scott lowered the firm's price target on Brown & Brown to $80 from $82 and keeps an Equal Weight rating on the shares. The insurance broker group has "derated sharply on fears of AI-driven disruption," the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now "more than discount" slower growth while overlooking durability of the broker business model and AI's potential to support productivity and margins. The analyst views AI as a "productivity enabler" for the brokers.

BERNSTEIN

  • SJM Bernstein upgraded J.M. Smucker to Outperform from Market Perform with a price target of $145, up from $121. The firm cites the continued deflation in green coffee costs and the arrival of activist Elliott Management for the upgrade. Elliott might drive portfolio changes and productivity improvements at Smucker, the analyst tells investors in a research note. Bernstein adds that green coffee commodity prices have deflated from all-time high prices above $4 per pound in 2025 to below $3.

BMO CAPITAL

  • BG BMO Capital analyst Andrew Strelzik raised the firm's price target on Bunge to $135 from $130 and keeps an Outperform rating on the shares. The company's investor day presentation was positive as the management laid out a framework to achieve the $15 mid-cycle EPS baseline by 2030, the analyst tells investors in a research note. BMO adds it has come away with greater confidence in Bunge's multi-year earnings trajectory.
  • MTDR BMO Capital raised the firm's price target on Matador to $65 from $60 and keeps an Outperform rating on the shares after meeting with its management. The firm remains positive on the company's differentiated story with Northern Delaware Core Acreage, strong operational performance, and above-average production growth, the analyst tells investors in a research note.
  • UNFI BMO Capital raised the firm's price target on United Natural Foods to $52 from $48 and keeps an Outperform rating on the shares. The company reported a solid beat on raise with Q2 earnings despite softer sales, the analyst tells investors in a research note. BMO adds that United Natural Foods continues to demonstrate strong execution of its network optimization strategy, which is ahead of schedule, and its EBITDA targets remain very achievable.
  • BNTX BMO Capital analyst Evan Seigerman lowered the firm's price target on BioNTech to $128 from $143 and keeps an Outperform rating on the shares. The company's underwhelming 2026 COVID guide and confusing CEO departure messaging inject uncertainty ahead of BioNTech's "major year for data", the analyst tells investors in a research note. BMO adds that the uncertainty associated with new leadership in light of a vast mid-to-late-stage pipeline and accelerating COVID revenue erosion gives the firm pause on the stock.

BOFA

  • LGND BofA initiated coverage of Ligand with a Buy rating and $244 price target. Citing a portfolio of more than 100 high-value commercial and development assets, increasing needs for flexible, non-dilutive capital in the industry and a lean cost structure, the analyst contends that the biopharma royalty firm can continue to deliver on its "aggressive earnings targets."

BTIG

  • APYX BTIG analyst Sam Eiber upgraded Apyx Medical to Buy from Neutral with a $6 price target. The firm cites positive early momentum with the Ayon launch, growing demand for skin tightening among consumers taking GLP-1s, and Apyx Medical's expansion opportunities outside the U.S. for the upgrade. Accelerating growth and cost controls offer greater visibility into the company's path to sustainable profitability, which had been a previous core concern, the analyst tells investors in a research note.
  • SI BTIG raised the firm's price target on Shoulder Innovations to $24 from $23 and keeps a Buy rating on the shares. The firm continues to view 2026 as a year of accelerating new customer acquisitions, with clear greenfield geographic expansion opportunities in key markets, as well as deepening ASC - Ambulatory Surgery Center - penetration and expanding new products, the analyst tells investors in a research note.

CANACCORD

  • PGNY Canaccord lowered the firm's price target on Progyny to $19 from $26 and keeps a Hold rating on the shares. The firm updated its model follwong Q4 results which suggests business trends appear stable but the uncertain outlook and environment keeps them cautious on the shares.
  • XGN Canaccord lowered the firm's price target on Exagen to $10 from $15 and keeps a Buy rating on the shares. The firm noted they reported inline Q4 results and said its target reduction is driven by more muted ASP and gross margin expansion in the near term, as well as reduced revenue growth assumptions in the out years of our 10-year DCF.

CITI

  • ISRG Citi upgraded Intuitive Surgical to Buy from Neutral with an unchanged price target of $590. The firm believes fundamentals in the U.S. medical technology sector remain "healthy" despite the recent volatility. Shares of Intuitive have fallen with the market, but the company is well positioned to grow sales at a double-digit pace while leveraging earnings, the analyst tells investors in a research note.
  • SYK Citi opened an "upside 90-day catalyst watch" on shares of Stryker while keeping a Buy rating on the name with a $420 price target. The firm believes fundamentals in the U.S. medical technology sector remain "healthy" despite the recent volatility. Stryker has reported consistent double-digit revenue and earnings growth, the analyst tells investors in a research note.
  • ABT Citi analyst Joanne Wuensch lowered the firm's price target on Abbott to $136 from $140 and keeps a Buy rating on the shares. The firm adjusted targets in the medical technology group post the Q4 reports. Sector fundamentals remain "healthy" despite the recent volatility, the analyst tells investors in a research note. Citi's top picks are iRhythm and Medtronic.
  • A Citi opened an "upside 90-day catalyst watch" on shares of Agilent while keeping a Buy rating on the name with a $185 price target. The share overhang of a potential transformational acquisition should be removed with Agilent's deal for Biocare Medical, the analyst tells investors in a research note. Citi sees the stock's multiple rebounding.
  • ICLR Citi analyst Patrick Donnelly lowered the firm's price target on Icon to $120 from $200 and keeps a Neutral rating on the shares. The firm updated models in the life science tools and diagnostics group post the Q4 reports. Citi sees room for upside to the Q1 outlooks if biopharma activity continues to improve. The firm named Agilent its top tools pick, Natera its top diagnostics pick, and Charles River its top contract research organization pick.

GOLDMAN SACHS

  • KSS Goldman Sachs lowered the firm's price target on Kohl's to $13 from $15 and keeps a Sell rating on the shares. The firm views the company's Q4 results as mixed. Kohl's below the line items offset its decelerating comp momentum and a sales miss, the analyst tells investors in a research note.

GUGGENHEIM

  • ACN Guggenheim analyst Jonathan Lee lowered the firm's price target on Accenture to $275 from $305 and keeps a Buy rating on the shares. The firm, which said in an earnings preview that it expects Accenture to raise the low end of its FY26 revenue outlook while maintaining the high end, cites industry-wide multiple compression for its reduced price target.

JPMORGAN

  • ORCL JPMorgan upgraded Oracle to Overweight from Neutral with a price target of $210, down from $230, following the fiscal Q3 report. The stock in premarket trading is up 11%, or $16.93, to $166.33. The firm cites the 55% decline in shares since mid-September and Oracle delivering on its growth acceleration for the upgrade. Investor sentiment on Oracle has shifted from "blind faith to widespread pessimism" over the attainability of its fiscal 2030 targets, the analyst tells investors in a research note. JPMorgan sees an improved risk/reward against the backdrop of the investor pessimism.
  • CTOS JPMorgan lowered the firm's price target on Custom Truck One Source to $6 from $6.50 and keeps an Underweight rating on the shares. The company reported a Q4 EBITDA beat but with a sales miss, the analyst tells investors in a research note. The firm updated the company's model post the Q4 report.

KEEFE BRUYETTE

  • FDUS Keefe Bruyette lowered the firm's price target on Fidus Investment to $20 from $21 and keeps an Outperform rating on the shares. The company reported a strong Q4 earnings beat on investment fundings, the analyst tells investors in a research note. Keefe expects Fidus shares to main a premium valuation relative to peers.
  • CIFR Keefe Bruyette lowered the firm's price target on Cipher Mining to $20 from $22 and keeps an Outperform rating on the shares. The firm reduced its 2026 abd 2027 revenue and EBITDA estimates for Cipher citing the reduced hash price, the company's anticipated exit from bitcoin mining in 2027, and higher spending. However, the analyst believes the market is overly discounting Cipher's existing leases or being too conservative on its 2026 leasing.
  • WULF Keefe Bruyette lowered the firm's price target on TeraWulf to $23 from $24 and keeps an Outperform rating on the shares. The firm reduced the company's EBITDA estimates to reflect higher spending and equity-method accounting for the Abernathy joint venture. Keefe also sees TeraWulf exiting mining by year-end. The 23% share pullback from the 52-week high on February 25 presents an "appealing buying opportunity," the analyst tells investors in a research note. Keefe believes investors are over-discounting current lease value or adopting an overly conservative view of the company's 2026 lease signings.

KEYBANC

  • AVAV KeyBanc lowered the firm's price target on AeroVironment to $295 from $330 and keeps an Overweight rating on the shares. Post AeroVironment's Q3 earnings/the firm's analysis, KeyBanc adjusts estimates. The firm cites recent changes to the SCAR program and timing in contract awards for the price target decrease. KeyBanc maintains that AeroVironment is positioned to capitalize on the proliferation of UAS/cUAS and increased government spending in defense and space-related programs. Should the conflict in Iran intensify, AeroVironment is positioned as one of the top beneficiaries, in KeyBanc's view.
  • XGN KeyBanc lowered the firm's price target on Exagen to $10 from $15 and keeps an Overweight rating on the shares. The firm notes the company posted Q4 earnings in line with the Street from a top-line perspective as the ASP headwind impact continued into Q4. Since the lower price was a Q3 one-off, comparisons will ease in the first half of 2026. While FY26 guidance is conservative, management has a strong reimbursement background and potential ASP upside exists in FY26 and FY27, KeyBanc argues.

MIZUHO

  • VICI Mizuho downgraded VICI Properties to Neutral from Outperform with an unchanged price target of $30. The firm cites valuation for the downgrade. At the current stock price, VICI offers less relative opportunity for outperformance, the analyst tells investors in a research note.
  • CNC Mizuho lowered the firm's price target on Centene to $41 from $47 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q4 report. Centene shares were down 14% following the company's comments at a competitor's conference yesterday, the analyst tells investors in a research note. Mizuho cites a more conservative valuation multiple pending greater clarity on the potential risk shifts if health insurance exchange dis-enrollment is worse than expectations for the target cut.
  • ELV Mizuho analyst Ann Hynes lowered the firm's price target on Elevance Health to $350 from $413 and keeps an Outperform rating on the shares. Elevance reiterated its 2026 guidance at a competitor conference and noted the Centers for Medicare and Medicaid Services sanctions are related to historical data submission processes and does not impact the company's current risk-adjustment processes, the analyst tells investors in a research note. The firm notes Elevance expects that any impact is currently embedded within 2026E guidance.
  • TNGX Mizuho raised the firm's price target on Tango Therapeutics to $20 from $19 and keeps an Outperform rating on the shares. The firm updated the company's model post the Q4 report.

OPPENHEIMER

  • OCGN Oppenheimer initiated coverage of Ocugen with an Outperform rating and $10 price target. The firm views Ocugen as an emerging gene therapy leader in blinding ocular disorders. The company's lead asset OCU400 is in Phase 3 for retinitis pigmentosa. A potential 2027 approval could provide near-term entry into a "sizable and poorly-met rare disease market opportunity," the analyst tells investors in a research note.

PIPER SANDLER

  • ORCL Piper Sandler analyst Billy Fitzsimmons lowered the firm's price target on Oracle to $210 from $240 to reflect the multiple de-rating across software, while keeping an Overweight rating on the shares. The firm says Oracle provided breadcrumbs in its Q3 earnings that should help partially ease investor concerns. Notably, demand for cloud computing for AI continues to grow faster than supply and as such, management expects to "comfortably meet and likely exceed" its growth rate forecast for FY27 and beyond.

RBC CAPITAL

  • LNT RBC Capital analyst Stephen D'Ambrisi initiated coverage of Alliant Energy with an Outperform rating and $82 price target. The firm sees conservatism in the company's outlook and believes it offers greater leverage than peers to incremental data center announcements. Alliant also has exposure to a "best-in-class regulatory framework" in Iowa, the analyst tells investors in a research note. RBC's 2029 earnings estimates for Alliant are above consensus.

SCOTIABANK

  • CX Scotiabank last night upgraded Cemex to Outperform from Sector Perform with a price target of $13.90, up from $13.50. The share selloff since the Iran conflict started is an overreaction, the analyst tells investors in a research note. Scotiabank sees a limited negative economic impact to Cemex in 2026. It also sees the possibility of improved energy security, which is believes is a key for energy-intensive industries such as cement. Scotiabank upgraded Cemex following the 17% share correction.

STIFEL

  • CCL Stifel analyst Steven Wieczynski lowered the firm's price target on Carnival to $35 from $40 and keeps a Buy rating on the shares. Investor sentiment across the cruise industry has "gone from solid to unstable/concerning in the blink of an eye," says the analyst, who believes the bar for Carnival's upcoming earnings release and guidance "has been massively lowered." The firm, which adjusted its estimates lower mostly to account for the recent spike in global fuel prices, believes cruise fundamentals remain "solid," but adds that "investors will not pay attention or care" until the overall geopolitical backdrop, including fuel prices, is more stable.

UBS

  • RPAY UBS lowered the firm's price target on Repay Holdings to $3.50 from $4 and keeps a Neutral rating on the shares. The firm updated estimates after Repay reported Q4 results and provided initial FY26 guidance calling for 7%-9% normalized revenue growth.
  • WSM UBS analyst Michael Lasser raised the firm's price target on Williams-Sonoma to $185 from $175 and keeps a Neutral rating on the shares. The firm, which thinks the company had "a solid holiday quarter," is expecting an in-line Q4 print and thinks focus will be on the puts and takes of FY26 margin expectations, the analyst tells investors in a preview.
  • ABM UBS analyst Joshua Chan lowered the firm's price target on ABM to $45 from $51 and keeps a Neutral rating on the shares after the company reported a fiscal Q1 EBITDA shortfall attributed to weather/mix impacting the Technical Solutions business. While valuation does not look "overly demanding," and growth has been "solid," the firm stays on sidelines as the margin outlook remains "choppy," the analyst tells investors.

WELLS FARGO

  • BLND Wells Fargo lowered the firm's price target on Blend Labs to $4 from $5 and keeps an Overweight rating on the shares. The firm notes Q4 revenue was in line, as better-than-expected mortgage was offset by softness in consumer banking. While a longer than expected journey, Wells sees Blend Labs holding stable and expects growth to ultimately bounce back as mortgage volumes improve.
  • APTV Wells Fargo lowered the firm's price target on Aptiv to $95 from $102 and keeps an Overweight rating on the shares. The firm notes Aptiv is 5% year-to-date, vs peers up 3% year-to-date. Like other auto growth names, performance reflects DRAM and macro concerns. Given the low valuation, Wells' base case upside is 30%. With a 2.4 times upside/downside ratio, the risk-reward is compelling, argues the firm.
  • UNFI Wells Fargo raised the firm's price target on United Natural Foods to $40 from $35 and keeps an Equal Weight rating on the shares. The firm notes the company's focus on efficiency and execution continues to pay off. United Natural Foods reported a solid bottom line beat and raise in Q2. Top-line momentum remains a key hurdle for the stock, but operations progress is clear.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

 

 

 

 

 

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

 

Monday March 9th

Economic Calendar: 

  • 10:00 AM ET                 Employment Trends for February

Earnings Calendar:

  • Earnings Before the Open: ACCO BETA DDD ELTK FCEL GBTG HRTG KFY NYAX SBEY SPRY ZIM
  • Earnings After the Close: ARQ CASY CHRS FLNT HPE KRO LFMD MTN MYO NPWR RAIL RPAY STXS VOYG YEXT ZVRA

Other Key Events:

  • Bank America Consumer & Retail conference, 3/9-3/12
  • Deutsche Bank 34th Annual Media, internet & Telecom Conference, 3/9-3/11, in Palm Beach, FL

Tuesday March 10th

Economic Calendar: 

  • 6:00 AM ET NFIB Small Business Optimism for February
  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 10:00 AM ET                 Existing Home Sales M/M for February
  • 12:00 PM ET WASDE crop report
  • 1:00 PM ET U.S. Treasury to sell $58B in 30 year notes
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: ABM ADCT APYX BNTX CMT CTOS ESPR GBLI INSE IPWR KSS KVHI LEGN NIO PRTH STGW UEC UNFI WLFX XGN
  • Earnings After the Close: ASM AVAV BBCP BODI CDRE DOMO EVLV FNV FOA GRPN IDT JOYY LDI NATR ORCL SO SIGA WEST

Other Key Events:

  • Bank America Consumer & Retail conference, 3/9-3/12
  • Cantor Technology Conference, 3/10-3/11
  • Citizens Life Sciences Conference, 3/10, in Miami, FL
  • Deutsche Bank 34th Annual Media, internet & Telecom Conference, 3/9-3/11, in Palm Beach, FL
  • RBC Capital 2026 Global Financials Conference, 3/10-3/11, in New York

Wednesday March 11th

Economic Calendar: 

  • 7:00 AM ET MBA Mortgage Applications Data
  • 8:30 AM ET                   Consumer Price Index (CPI) M/M for February
  • 8:30 AM ET                   Consumer Price Index (CPI) Y/Y for February
  • 8:30 AM ET                   Core CPI, Ex: Food & Energy M/M for February
  • 8:30 AM ET                   Core CPI, Ex: Food & Energy Y/Y for February
  • 10:30 AM ET                 Weekly DOE Inventory Data
  • 1:00 PM ET U.S. Treasury to sell $42B in 10-year notes
  • 2:00 PM ET                    Federal Budget for February

Earnings Calendar:

  • Earnings Before the Open: ACTG BWAY BWEN CPB CVGI CXM KMDA KPLT OPFI SDHC SERV TH
  • Earnings After the Close: ARIS ASTL BMBL CDXS CINT CURI DMRC DSGC DSP FOSL FTK HPK NOA NTSK NVGS ODC PATH SFIX SID TBBB TLYS TTGT VEL WLTH WOOF

Other Key Events:

  • Bank America Consumer & Retail conference, 3/9-3/12
  • Cantor Technology Conference, 3/10-3/11
  • Deutsche Bank 34th Annual Media, internet & Telecom Conference, 3/9-3/11, in Palm Beach, FL
  • RBC Capital 2026 Global Financials Conference, 3/10-3/11, in New York
  • Stifel NYC technology 1-on-1 Conference, 3/11 in New York

Thursday March 12th

Economic Calendar: 

  • 8:30 AM ET                   Weekly Jobless Claims
  • 8:30 AM ET                   Continuing Claims
  • 8:30 AM ET                   Housing Starts M/M for January
  • 8:30 AM ET                   Building Permits M/M for January
  • 8:30 AM ET                   International Trade for January
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data
  • 1:00 PM ET U.S. Treasury to sell $25B in 30-year notes

Earnings Calendar:

  • Earnings Before the Open: ACDC BBW BLDP CION DG DKS FUTU GAMB HBIO JG LCUT LI OLLI PHAR REFI RPID SEAT SGA SNBR SNDL SUNS UONEK VFF VRA YMM
  • Earnings After the Close: ABX ADBE ALLO ANGX AOUT APEI AVO BZFD CVGW EVCM FNKO GDOT HCAT JCAP JYNT KRMD KRT LEN LMNR LOCO LPRO MAPS MNR NKTR OFRM PD PXLW QRHC RBRK RWAY S SKIN RBCH TTAN ULTA VERI VUZI VXRT WPM ZUMZ

Other Key Events:

  • Bank America Consumer & Retail conference, 3/9-3/12
  • Bank America Information & Business Services Conference 3/12, in New York

Friday March 13th

Economic Calendar: 

  • 8:30 AM ET                   Personal income M/M for January
  • 8:30 AM ET                   Personal Spending M/M for January
  • 8:30 AM ET                   Personal Consumption Expenditures (PCE) Price Index M/M for January
  • 8:30 AM ET                   Personal Consumption Expenditures (PCE) Price Index Y/Y for January
  • 8:30 AM ET                   Core PCE Price Index M/M for January
  • 8:30 AM ET                   Core PCE Price Index Y/Y for January
  • 8:30 AM ET                   Gross Domestic Product (GDP) 2nd estimate for Q3
  • 8:30 AM ET GDP Consumer Spending 2nd estimate for Q3
  • 8:30 AM ET GDP Price Deflator for Q3 2nd estimate
  • 8:30 AM ET PCE Prices for Q3-preliminary
  • 8:30 AM ET                   Core PCE Prices for Q3-preliminary
  • 10:00 AM ET                 JOLTs Job Openings for January
  • 10:00 AM ET                 University of Michigan Confidence for March-prelim
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: ACXP BETR EEX RLX VEON

 

 

.

As a value-added service exclusive to Regal Securities account holders, The Hammerstone Report is available to read daily on the trading platform.

Hammerstone Inc. (the “Report”) provides information and data and does NOT provide any individual investment advice or money management assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity.

Content is provided for educational and informational purposes only and Regal Securities cannot attest to its accuracy or completeness. No information provided has been endorsed by Regal Securities and does not constitute a recommendation by Regal Securities to buy or sell a particular investment. You are solely responsible for your own investment decisions and Regal Securities makes no investment recommendations and does not provide financial, tax, or legal advice. Regal Securities may provide links to internet sites maintained by third parties. Unless expressly stated otherwise, links in these reports are not sponsored by nor are they the responsibility of Regal Securities. Regal Securities has not verified the content, accuracy, or opinions expressed on any links in these reports and disclaims any warranty or liability for damages associated therewith.

Copyright 2006-2026 Regal Securities, Inc., Member FINRA/SIPC | Important Disclosures

Your privacy is important to us; see our Privacy Policy for details.

Regal Securities, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025
Website: www.regalsecurities.com | Toll-free: 1-877-488-6534
Representatives are available Monday through Friday from 8:00 a.m. to 5:00 p.m. EST.